{"id":236019,"date":"2015-10-19T18:57:24","date_gmt":"2015-10-19T17:57:24","guid":{"rendered":"http:\/\/www.pressenza.com\/es\/?p=236019"},"modified":"2015-10-19T18:57:50","modified_gmt":"2015-10-19T17:57:50","slug":"financian-produccion-de-medicamentos-huerfanos","status":"publish","type":"post","link":"https:\/\/www.pressenza.com\/es\/2015\/10\/financian-produccion-de-medicamentos-huerfanos\/","title":{"rendered":"Financian producci\u00f3n de medicamentos hu\u00e9rfanos"},"content":{"rendered":"<div id=\"copete_amp\" class=\"copete\"><em>El desarrollo de un complejo industrial en Viedma dedicado a producir a escala piloto principios activos farmac\u00e9uticos y medicamentos nanom\u00e9tricos hu\u00e9rfanos que no se elaboran en nuestro pa\u00eds recibi\u00f3 financiamiento por $ 11,75 millones del Ministerio de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n Productiva.<\/em><\/div>\n<div id=\"cuerpo_amp\" class=\"texto\">\n<p>La Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica adjudic\u00f3 un subsidio de $11.749.900 para financiar la instalaci\u00f3n de un complejo farmoqu\u00edmico en la ciudad de Viedma, R\u00edo Negro, con el objetivo de producir integralmente a escala piloto, principios activos farmac\u00e9uticos y medicamentos nanom\u00e9tricos hu\u00e9rfanos, que abastezcan al mercado argentino y mundial.<\/p>\n<p>El proyecto ser\u00e1 llevado adelante por un consorcio p\u00fablico privado integrado por el laboratorio Prozome, organismo dependiente del Ministerio de Salud de R\u00edo Negro y principal productor de medicamentos de esa provincia;\u00a0 y la empresa INVAP Sociedad del Estado, dedicada al desarrollo de proyectos complejos de alta tecnolog\u00eda. La iniciativa fue aprobada en el marco de la convocatoria \u201cFondo de Innovaci\u00f3n Tecnol\u00f3gica Regional (FITR)\u00a0 Salud &#8211; 2013\u201d que administra el Fondo Argentino Sectorial (FONARSEC) de la Agencia.<\/p>\n<p>El financiamiento incluye la creaci\u00f3n del establecimiento farmoqu\u00edmico para sintetizar inicialmente antiparasitarios antihelm\u00ednticos derivados del imidazol, como el albendazol y el nifurtimox, empleados en el tratamiento de la enfermedad de Chagas.<\/p>\n<p>Para alcanzar estos objetivos se deber\u00e1 equipar al laboratorio Prozome en el que se desarrollar\u00e1n los medicamentos preferentemente de uso pedi\u00e1trico que se consideran hu\u00e9rfanos, hasta la escala piloto.<\/p>\n<p>De esta manera, se destinar\u00e1n recursos en equipar la planta, capacitar a los especialistas hasta alcanzar los est\u00e1ndares internacionales requeridos, profundizar el desarrollo y la investigaci\u00f3n aplicada de farmoqu\u00edmicos de origen natural, e implementar plataformas pre-cl\u00ednicas siguiendo los lineamientos dispuestos por las autoridades sanitarias nacionales e internacionales, que permitan caracterizar los riesgos y garantizar la efectividad de las principios activos sintetizados.<\/p>\n<p>Adem\u00e1s, se buscar\u00e1 fomentar la investigaci\u00f3n aplicada, la transferencia tecnol\u00f3gica y la innovaci\u00f3n en la regi\u00f3n patag\u00f3nica, formando recursos humanos en diferentes campos de especializaci\u00f3n y propiciando, adem\u00e1s, la participaci\u00f3n de investigadores argentinos en proyectos de cooperaci\u00f3n internacional.<\/p>\n<p>El laboratorio Prozome y la empresa INVAP aportar\u00e1n $2.937.475 como contraparte del proyecto, que tendr\u00e1 un plazo de ejecuci\u00f3n de 36 meses, por lo que la inversi\u00f3n total comprometida ascender\u00e1 a $14.687.375.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>El desarrollo de un complejo industrial en Viedma dedicado a producir a escala piloto principios activos farmac\u00e9uticos y medicamentos nanom\u00e9tricos hu\u00e9rfanos que no se elaboran en nuestro pa\u00eds recibi\u00f3 financiamiento por $ 11,75 millones del Ministerio de Ciencia, Tecnolog\u00eda e&hellip;<\/p>\n","protected":false},"author":87,"featured_media":236020,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[497,149,1239,67],"tags":[26,15619,12826,20974,20973],"class_list":["post-236019","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ciencia-tecnologia","category-comunicados-de-prensa","category-salud","category-sudamerica","tag-argentina","tag-industria-farmaceutica","tag-medicamentos","tag-medicamentos-huerfanos","tag-viedma"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Financian producci\u00f3n de medicamentos hu\u00e9rfanos<\/title>\n<meta name=\"description\" content=\"El desarrollo de un complejo industrial en Viedma dedicado a producir a escala piloto principios activos farmac\u00e9uticos y medicamentos nanom\u00e9tricos\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pressenza.com\/es\/2015\/10\/financian-produccion-de-medicamentos-huerfanos\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Financian producci\u00f3n de medicamentos hu\u00e9rfanos\" \/>\n<meta property=\"og:description\" content=\"El desarrollo de un complejo industrial en Viedma dedicado a producir a escala piloto principios activos farmac\u00e9uticos y medicamentos nanom\u00e9tricos\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pressenza.com\/es\/2015\/10\/financian-produccion-de-medicamentos-huerfanos\/\" \/>\n<meta property=\"og:site_name\" content=\"Pressenza\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/PressenzaItalia\" \/>\n<meta property=\"article:published_time\" content=\"2015-10-19T17:57:24+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2015-10-19T17:57:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.pressenza.com\/wp-content\/uploads\/2015\/10\/Medicamentos_huerfanos_en_Viedma.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"400\" \/>\n\t<meta property=\"og:image:height\" content=\"266\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Redacci\u00f3n Argentina\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@pressenza\" \/>\n<meta name=\"twitter:site\" content=\"@PressenzaIPA\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Redacci\u00f3n Argentina\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.pressenza.com\/es\/2015\/10\/financian-produccion-de-medicamentos-huerfanos\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.pressenza.com\/es\/2015\/10\/financian-produccion-de-medicamentos-huerfanos\/\"},\"author\":{\"name\":\"Redacci\u00f3n Argentina\",\"@id\":\"https:\/\/www.pressenza.com\/es\/#\/schema\/person\/f3c4979d81833b2e034fd4a1965d5ca7\"},\"headline\":\"Financian producci\u00f3n de medicamentos hu\u00e9rfanos\",\"datePublished\":\"2015-10-19T17:57:24+00:00\",\"dateModified\":\"2015-10-19T17:57:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.pressenza.com\/es\/2015\/10\/financian-produccion-de-medicamentos-huerfanos\/\"},\"wordCount\":405,\"publisher\":{\"@id\":\"https:\/\/www.pressenza.com\/es\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.pressenza.com\/es\/2015\/10\/financian-produccion-de-medicamentos-huerfanos\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.pressenza.com\/wp-content\/uploads\/2015\/10\/Medicamentos_huerfanos_en_Viedma.jpg\",\"keywords\":[\"Argentina\",\"industria farmac\u00e9utica\",\"Medicamentos\",\"medicamentos hu\u00e9rfanos\",\"Viedma\"],\"articleSection\":[\"Ciencia y Tecnolog\u00eda\",\"Comunicados de Prensa\",\"Salud\",\"Sudam\u00e9rica\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.pressenza.com\/es\/2015\/10\/financian-produccion-de-medicamentos-huerfanos\/\",\"url\":\"https:\/\/www.pressenza.com\/es\/2015\/10\/financian-produccion-de-medicamentos-huerfanos\/\",\"name\":\"Financian producci\u00f3n de medicamentos hu\u00e9rfanos\",\"isPartOf\":{\"@id\":\"https:\/\/www.pressenza.com\/es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.pressenza.com\/es\/2015\/10\/financian-produccion-de-medicamentos-huerfanos\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.pressenza.com\/es\/2015\/10\/financian-produccion-de-medicamentos-huerfanos\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.pressenza.com\/wp-content\/uploads\/2015\/10\/Medicamentos_huerfanos_en_Viedma.jpg\",\"datePublished\":\"2015-10-19T17:57:24+00:00\",\"dateModified\":\"2015-10-19T17:57:50+00:00\",\"description\":\"El desarrollo de un complejo industrial en Viedma dedicado a producir a escala piloto principios activos farmac\u00e9uticos y medicamentos nanom\u00e9tricos\",\"breadcrumb\":{\"@id\":\"https:\/\/www.pressenza.com\/es\/2015\/10\/financian-produccion-de-medicamentos-huerfanos\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.pressenza.com\/es\/2015\/10\/financian-produccion-de-medicamentos-huerfanos\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.pressenza.com\/es\/2015\/10\/financian-produccion-de-medicamentos-huerfanos\/#primaryimage\",\"url\":\"https:\/\/www.pressenza.com\/wp-content\/uploads\/2015\/10\/Medicamentos_huerfanos_en_Viedma.jpg\",\"contentUrl\":\"https:\/\/www.pressenza.com\/wp-content\/uploads\/2015\/10\/Medicamentos_huerfanos_en_Viedma.jpg\",\"width\":400,\"height\":266},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.pressenza.com\/es\/2015\/10\/financian-produccion-de-medicamentos-huerfanos\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.pressenza.com\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Financian producci\u00f3n de medicamentos hu\u00e9rfanos\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.pressenza.com\/es\/#website\",\"url\":\"https:\/\/www.pressenza.com\/es\/\",\"name\":\"Pressenza\",\"description\":\"International Press Agency\",\"publisher\":{\"@id\":\"https:\/\/www.pressenza.com\/es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.pressenza.com\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.pressenza.com\/es\/#organization\",\"name\":\"Pressenza\",\"url\":\"https:\/\/www.pressenza.com\/es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.pressenza.com\/es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.pressenza.com\/wp-content\/uploads\/2022\/10\/pressenza_logo_200x200.jpg\",\"contentUrl\":\"https:\/\/www.pressenza.com\/wp-content\/uploads\/2022\/10\/pressenza_logo_200x200.jpg\",\"width\":200,\"height\":200,\"caption\":\"Pressenza\"},\"image\":{\"@id\":\"https:\/\/www.pressenza.com\/es\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/PressenzaItalia\",\"https:\/\/x.com\/PressenzaIPA\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.pressenza.com\/es\/#\/schema\/person\/f3c4979d81833b2e034fd4a1965d5ca7\",\"name\":\"Redacci\u00f3n Argentina\",\"description\":\"News from the Pressenza Bureau in Argentina.\",\"sameAs\":[\"https:\/\/x.com\/pressenza\"],\"url\":\"https:\/\/www.pressenza.com\/es\/author\/redaccion-argentina\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Financian producci\u00f3n de medicamentos hu\u00e9rfanos","description":"El desarrollo de un complejo industrial en Viedma dedicado a producir a escala piloto principios activos farmac\u00e9uticos y medicamentos nanom\u00e9tricos","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pressenza.com\/es\/2015\/10\/financian-produccion-de-medicamentos-huerfanos\/","og_locale":"es_ES","og_type":"article","og_title":"Financian producci\u00f3n de medicamentos hu\u00e9rfanos","og_description":"El desarrollo de un complejo industrial en Viedma dedicado a producir a escala piloto principios activos farmac\u00e9uticos y medicamentos nanom\u00e9tricos","og_url":"https:\/\/www.pressenza.com\/es\/2015\/10\/financian-produccion-de-medicamentos-huerfanos\/","og_site_name":"Pressenza","article_publisher":"https:\/\/www.facebook.com\/PressenzaItalia","article_published_time":"2015-10-19T17:57:24+00:00","article_modified_time":"2015-10-19T17:57:50+00:00","og_image":[{"width":400,"height":266,"url":"https:\/\/www.pressenza.com\/wp-content\/uploads\/2015\/10\/Medicamentos_huerfanos_en_Viedma.jpg","type":"image\/jpeg"}],"author":"Redacci\u00f3n Argentina","twitter_card":"summary_large_image","twitter_creator":"@pressenza","twitter_site":"@PressenzaIPA","twitter_misc":{"Escrito por":"Redacci\u00f3n Argentina","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.pressenza.com\/es\/2015\/10\/financian-produccion-de-medicamentos-huerfanos\/#article","isPartOf":{"@id":"https:\/\/www.pressenza.com\/es\/2015\/10\/financian-produccion-de-medicamentos-huerfanos\/"},"author":{"name":"Redacci\u00f3n Argentina","@id":"https:\/\/www.pressenza.com\/es\/#\/schema\/person\/f3c4979d81833b2e034fd4a1965d5ca7"},"headline":"Financian producci\u00f3n de medicamentos hu\u00e9rfanos","datePublished":"2015-10-19T17:57:24+00:00","dateModified":"2015-10-19T17:57:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.pressenza.com\/es\/2015\/10\/financian-produccion-de-medicamentos-huerfanos\/"},"wordCount":405,"publisher":{"@id":"https:\/\/www.pressenza.com\/es\/#organization"},"image":{"@id":"https:\/\/www.pressenza.com\/es\/2015\/10\/financian-produccion-de-medicamentos-huerfanos\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pressenza.com\/wp-content\/uploads\/2015\/10\/Medicamentos_huerfanos_en_Viedma.jpg","keywords":["Argentina","industria farmac\u00e9utica","Medicamentos","medicamentos hu\u00e9rfanos","Viedma"],"articleSection":["Ciencia y Tecnolog\u00eda","Comunicados de Prensa","Salud","Sudam\u00e9rica"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.pressenza.com\/es\/2015\/10\/financian-produccion-de-medicamentos-huerfanos\/","url":"https:\/\/www.pressenza.com\/es\/2015\/10\/financian-produccion-de-medicamentos-huerfanos\/","name":"Financian producci\u00f3n de medicamentos hu\u00e9rfanos","isPartOf":{"@id":"https:\/\/www.pressenza.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.pressenza.com\/es\/2015\/10\/financian-produccion-de-medicamentos-huerfanos\/#primaryimage"},"image":{"@id":"https:\/\/www.pressenza.com\/es\/2015\/10\/financian-produccion-de-medicamentos-huerfanos\/#primaryimage"},"thumbnailUrl":"https:\/\/www.pressenza.com\/wp-content\/uploads\/2015\/10\/Medicamentos_huerfanos_en_Viedma.jpg","datePublished":"2015-10-19T17:57:24+00:00","dateModified":"2015-10-19T17:57:50+00:00","description":"El desarrollo de un complejo industrial en Viedma dedicado a producir a escala piloto principios activos farmac\u00e9uticos y medicamentos nanom\u00e9tricos","breadcrumb":{"@id":"https:\/\/www.pressenza.com\/es\/2015\/10\/financian-produccion-de-medicamentos-huerfanos\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pressenza.com\/es\/2015\/10\/financian-produccion-de-medicamentos-huerfanos\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.pressenza.com\/es\/2015\/10\/financian-produccion-de-medicamentos-huerfanos\/#primaryimage","url":"https:\/\/www.pressenza.com\/wp-content\/uploads\/2015\/10\/Medicamentos_huerfanos_en_Viedma.jpg","contentUrl":"https:\/\/www.pressenza.com\/wp-content\/uploads\/2015\/10\/Medicamentos_huerfanos_en_Viedma.jpg","width":400,"height":266},{"@type":"BreadcrumbList","@id":"https:\/\/www.pressenza.com\/es\/2015\/10\/financian-produccion-de-medicamentos-huerfanos\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.pressenza.com\/es\/"},{"@type":"ListItem","position":2,"name":"Financian producci\u00f3n de medicamentos hu\u00e9rfanos"}]},{"@type":"WebSite","@id":"https:\/\/www.pressenza.com\/es\/#website","url":"https:\/\/www.pressenza.com\/es\/","name":"Pressenza","description":"International Press Agency","publisher":{"@id":"https:\/\/www.pressenza.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pressenza.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.pressenza.com\/es\/#organization","name":"Pressenza","url":"https:\/\/www.pressenza.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.pressenza.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/www.pressenza.com\/wp-content\/uploads\/2022\/10\/pressenza_logo_200x200.jpg","contentUrl":"https:\/\/www.pressenza.com\/wp-content\/uploads\/2022\/10\/pressenza_logo_200x200.jpg","width":200,"height":200,"caption":"Pressenza"},"image":{"@id":"https:\/\/www.pressenza.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/PressenzaItalia","https:\/\/x.com\/PressenzaIPA"]},{"@type":"Person","@id":"https:\/\/www.pressenza.com\/es\/#\/schema\/person\/f3c4979d81833b2e034fd4a1965d5ca7","name":"Redacci\u00f3n Argentina","description":"News from the Pressenza Bureau in Argentina.","sameAs":["https:\/\/x.com\/pressenza"],"url":"https:\/\/www.pressenza.com\/es\/author\/redaccion-argentina\/"}]}},"place":"Viedma","original_article_url":"","_links":{"self":[{"href":"https:\/\/www.pressenza.com\/es\/wp-json\/wp\/v2\/posts\/236019","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pressenza.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pressenza.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pressenza.com\/es\/wp-json\/wp\/v2\/users\/87"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pressenza.com\/es\/wp-json\/wp\/v2\/comments?post=236019"}],"version-history":[{"count":0,"href":"https:\/\/www.pressenza.com\/es\/wp-json\/wp\/v2\/posts\/236019\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pressenza.com\/es\/wp-json\/wp\/v2\/media\/236020"}],"wp:attachment":[{"href":"https:\/\/www.pressenza.com\/es\/wp-json\/wp\/v2\/media?parent=236019"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pressenza.com\/es\/wp-json\/wp\/v2\/categories?post=236019"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pressenza.com\/es\/wp-json\/wp\/v2\/tags?post=236019"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}